128 results
Page 4 of 7
S-4
EX-10.56
5sowntflsj027dsxiy5j
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.43
94yj6 wokaqg18cladu
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.54
emn1d535j4x g2
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.63
v1zcscq47l
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.49
86cl0 qwse3mx
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.64
8vvy0ab
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.61
wdy9js0 2n0
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
8-K
EX-10.1
atr1a 7ls7ado
4 Oct 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.1
x781lts zggmpnj93
1 Aug 19
Departure of Directors or Certain Officers
7:00am
8-K
EX-10.2
mf9 wftwxbgd93dx
1 Aug 19
Departure of Directors or Certain Officers
7:00am
8-K
EX-10.1
g8d rukckv0
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
8-K
EX-10.2
kht 6z96z8fp
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
8-K
EX-10.1
7beun
11 May 17
Conatus Announces Proposed Public Offering of Common Stock
12:00am